|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 19186140.0 (espacenet) (Federated) (European Patent Register), 20160516 | | Patent/reg. no. and date | DK/EP 3574907, 20230823 | | Publication date | 20191204 | | Priority no. and date | US 201562162870 P, 20150518 | | EP pub. no. and date |
EP 3574907 20191204 | | Effective date | | | Applicant/owner | KaNDy Therapeutics Limited, 400 South Oak Way
Reading, Berkshire RG2 6AD, GB | | Applicant ref. no. | | | Inventor | TROWER, Mike, P.O. Box
c/o NeRRe Therapeutics Limited
Stevenage Bioscience Catalyst
Incubator Building
Gunnels Wood Road
Stevenage, Hertfordshire SG1 2FX, GB | | Representative | | | Opponent | | | IPC Class | A61K 31/5383 (2006.01) , A61K 45/06 (2006.01) , A61K 9/00 (2006.01) , A61P 15/00 (2006.01) , A61P 15/02 (2006.01) , A61P 15/12 (2006.01) , A61P 43/00 (2006.01) , A61P 5/24 (2006.01) | | Title | AN NK-1/NK-3 RECEPTOR ANTAGONIST FOR THE TREATMENT OF SEX-HORMONE-DEPENDENT DISEASES | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent ugyldig | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
